Trials by Active Ingredient
Tapentadol
| Trial identifier (Sponsor): | KF5503/68 |
| Trade name: | Palexia®, Nucynta®, Yantil® |
| INN / Sponsor substance code: | Tapentadol |
| Trial title: | Open-label evaluation of the pharmacokinetic profile, safety, and efficacy of tapentadol oral solution for the treatment of post-surgical pain in children and adolescents aged from 2 years to less than 18 years |
| Brief title: | -- |
| Trial indication: | Post-surgical pain |
| Trial status: | Completed |
| Results posted: | Yes (ClinicalTrials.gov, Eudra CT) |
| PubMed unique identifier [PMID]: | -- |
| First subject enrolled: | 15 Nov 2012 |
| Last subject completed: | 24 Feb 2014 |
| UTN (WHO): | -- |
| ClinicalTrials.gov identifier: | NCT01729728 |
| Eudra CT identifier: | 2013-002016-27 |
| Available for data sharing: | No |
| Trial phase: | 2 |
